Jupiter Topco LLC Makes New Investment in HCA Healthcare, Inc. $HCA

Jupiter Topco LLC purchased a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, according to its most recent filing with the SEC. The firm purchased 951,903 shares of the company’s stock, valued at approximately $371,138,000. Jupiter Topco LLC owned 0.44% of HCA Healthcare at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in HCA. BlackRock Inc. bought a new position in HCA Healthcare during the second quarter worth about $5,069,974,000. State Street Corp lifted its holdings in shares of HCA Healthcare by 1.0% during the 4th quarter. State Street Corp now owns 7,566,643 shares of the company’s stock valued at $3,532,563,000 after purchasing an additional 76,039 shares in the last quarter. Capital World Investors raised its holdings in HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after buying an additional 40,086 shares during the period. Geode Capital Management LLC increased its position in shares of HCA Healthcare by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after acquiring an additional 13,565 shares in the last quarter. Finally, Norges Bank acquired a new position in HCA Healthcare in the 4th quarter worth $1,262,513,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.1%

Shares of NYSE HCA opened at $428.90 on Wednesday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The stock has a 50 day moving average of $398.59 and a 200-day moving average of $442.83. The company has a market capitalization of $92.86 billion, a P/E ratio of 14.36, a P/E/G ratio of 1.49 and a beta of 1.10.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter last year, the firm posted $6.84 EPS. The company’s quarterly revenue was up 8.7% on a year-over-year basis. Analysts predict that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

Analysts Set New Price Targets

HCA has been the subject of a number of research reports. Argus decreased their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Cantor Fitzgerald reduced their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Raymond James Financial set a $528.00 price target on shares of HCA Healthcare in a research report on Tuesday, July 7th. JPMorgan Chase & Co. reduced their price target on HCA Healthcare from $490.00 to $425.00 and set a “neutral” rating for the company in a research report on Thursday, August 20th. Finally, Robert W. Baird dropped their price objective on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a research note on Monday, July 27th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.